» Articles » PMID: 1062636

[Pharmakokinetics of Hydroxy-urea. Therapy of Acute Myeoblastic Leukemias Using Synchronization and Recruitment Effects (author' Transl)]

Overview
Journal Klin Wochenschr
Specialty General Medicine
Date 1976 Mar 1
PMID 1062636
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

By a plasma-concentration of hydroxy-urea (HU) higher than 0.5-2.2x10(-4)M the DNA-synthesis in leukemia cells was blocked reversibly in 9 patients. The plasma half-time of HU varied between 120 and 198 min. To synchronize leukemic cell populations the DNS-synthesis was blocked over a period of 36 hours by maintaining the HU-concentration above the critical lower level. In a second phase-specific therapeutic step cytosine-arabinoside (AraC) was given 4 times in a dose of 1 mg/kg each. A recruitment after the application of AarC made more cells available for the next following synchronization step. 4 acute myeloblastic leukemias with high peripheral cell counts were treated according to this schedule. One patient is still in complete remission for now 14 month. This synchronization/recruitment schedule seems to be successful in acute myeloblastic leukemias with high proliferation rates measured by biochemical and cytokinetic methods.

Citing Articles

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.

Rudd S, Tsesmetzis N, Sanjiv K, Paulin C, Sandhow L, Kutzner J EMBO Mol Med. 2020; 12(3):e10419.

PMID: 31950591 PMC: 7059017. DOI: 10.15252/emmm.201910419.


In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.

Camplejohn R, Schultze B, Maurer W Br J Cancer. 1977; 35(5):546-56.

PMID: 861145 PMC: 2025495. DOI: 10.1038/bjc.1977.88.


[Present state in synchronization therapy of malignant tumors and acute leukemias (author's transl)].

Sauer H, Wilmanns W Klin Wochenschr. 1976; 54(5):197-202.

PMID: 768630 DOI: 10.1007/BF01469125.


[Influence of hydroxyurea on DNA synthesis of human bone marrow in vivo (author's transl)].

Hartenstein R, ERTL E, Possinger K, EHRHART H Klin Wochenschr. 1979; 57(21):1191-3.

PMID: 513612 DOI: 10.1007/BF01491760.


[Partial synchronization of tumor cells in vivo with hydroxyurea (author's transl)].

Hartenstein R, Pfundmair K, Possinger K Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977; 88(3):261-72.

PMID: 140543 DOI: 10.1007/BF00305364.

References
1.
Maidhof R, Jellinghaus W, Schultze B, Maurer W . [Experimental and theoretical studies on the in-vivo production of a partially synchronous proliferating cell population with vincristine]. Dtsch Med Wochenschr. 1975; 100(2):54-6. View

2.
Rajewsky M, Hulser D, FABRICIUS E . [Studies on synchronisation in vivo: temporary inhibition of DNA synthesis in normal and malignant mammalian cell systems with hydroxyurea]. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1971; 76(4):266-92. DOI: 10.1007/BF00304031. View

3.
Lohrmann H, Graw C, Graw Jr R . Stimulated lymphocyte cultures: responder recruitment and cell cycle kinetics. J Exp Med. 1974; 139(5):1037-48. PMC: 2139670. DOI: 10.1084/jem.139.5.1037. View

4.
Lin H . Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells. Cancer Res. 1973; 33(7):1716-20. View

5.
Rajewsky M . Synchronisation in vivo: kinetics of a malignant cell system following temporary inhibition of DNA synthesis with hydroxyurea. Exp Cell Res. 1970; 60(2):269-76. DOI: 10.1016/0014-4827(70)90514-8. View